Covaxin is still in its Phase III trials. Approval should not be given in a hurry, more data has to be collected on its efficacy and safety, says Dr Kafeel Khan
Though some new vaccines in the pipeline look promising, there are several challenges to be met before they can be effectively deployed and administered.